word
count
text
word
count
right
reserv
reus
allow
without
permiss
abstract
exoribonucleas
coronaviru
cov
nonstructur
protein
mediat
rna
proofread
genom
replic
exon
catalyt
residu
arrang
three
motif
de
ii
e
iii
alanin
substitut
motif
residu
aa
four
nucleotid
substitut
murin
hepat
viru
mhv
sarscov
yield
viabl
mutant
impair
replic
fit
increas
mutat
rate
attenu
virul
vivo
despit
impair
mhvand
sarscov
exon
motif
aa
mutant
exonaa
revert
motif
divers
vitro
vivo
environ
suggest
profound
fit
barrier
prevent
motif
revers
test
hypothesi
engin
mhvexonaa
nucleotid
mutat
along
genet
pathway
aatod
revers
show
engin
intermedi
revert
viabl
increas
replic
competit
fit
compar
mhvexonaa
contrast
low
passag
aa
show
increas
replic
competit
fit
without
revers
exonaa
final
engin
revers
exonaa
exond
presenc
exonaa
adapt
mutat
result
signific
fit
loss
result
demonstr
revers
possibl
least
one
altern
adapt
pathway
rapidli
advantag
intermedi
revert
may
alter
genet
background
render
revers
detriment
fit
result
provid
evolutionari
rational
lack
exonaa
revers
illumin
potenti
multiprotein
replicas
interact
coevolut
support
futur
studi
aim
stabil
attenu
cov
exonaa
mutant
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
coronavirus
encod
exoribonucleas
exon
import
viral
replic
fit
virul
yet
coronavirus
defect
exon
exonaa
revert
divers
experiment
condit
studi
identifi
multipl
impedi
aa
revers
show
exonaa
revers
possibl
evolutionarili
unfavor
instead
compensatori
mutat
outsid
exonaa
motif
access
benefici
partial
revers
also
show
coevolut
replicas
protein
longterm
passag
partial
compens
exonaa
motif
render
viru
inhospit
revert
exon
result
reveal
evolutionari
basi
genet
stabil
inactiv
mutat
illumin
complex
function
evolutionari
relationship
coronaviru
replicas
protein
identifi
potenti
mechan
stabil
exonaa
coronaviru
mutant
right
reserv
reus
allow
without
permiss
rapid
evolut
rna
virus
repres
signific
challeng
prevent
treat
erad
rna
viral
diseas
high
mutat
rate
rna
virus
gener
extens
opportun
overcom
evolutionari
hurdl
antivir
drug
host
immun
engin
attenu
chang
evolutionari
pathway
travers
rna
virus
shape
natur
select
favor
evolutionari
trajectori
other
base
whether
mutat
benefici
deleteri
neutral
predict
like
result
rna
viru
evolut
import
step
anticip
viral
emerg
develop
escaperesist
antivir
drug
vaccin
coronavirus
cov
famili
positivesens
rna
virus
caus
human
ill
rang
common
cold
sever
lethal
respiratori
diseas
cov
encod
proofread
exoribonucleas
within
nonstructur
protein
critic
replic
fidel
fit
virul
exoninactiv
propos
strategi
liveattenu
vaccin
develop
member
deddh
superfamili
exonucleas
cov
exon
hydrolyz
nucleotid
use
four
metalcoordin
amino
acid
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
exon
activ
site
mutant
alphacoronavirus
includ
transmiss
gastroenter
viru
yet
recov
propos
lethal
replic
infect
prolong
passag
tissu
cultur
follow
treatment
multipl
nucleosid
analogu
sarscovexonaa
also
stabl
acut
persist
anim
infect
immunocompet
immunecompromis
mice
lack
primari
revers
due
simpli
reduc
adapt
capac
sarscovand
mhvexonaa
adapt
increas
replic
strikingli
longterm
passag
mhvexonaa
passag
yield
highli
fit
popul
directli
compens
defect
proofread
evolut
like
highfidel
rdrp
requir
mutat
four
site
figur
viral
mutat
rate
absenc
proofread
rang
mutat
per
nucleotid
per
round
replic
assum
exonaa
mutat
rate
account
codon
degeneraci
probabl
restor
nativ
amino
acid
sequenc
singl
round
replic
rare
exonaa
titer
exceed
pfuml
unlik
exonaa
could
navig
genet
barrier
singl
infecti
cycl
thu
hypothes
exonaa
revers
possibl
would
proceed
increment
identifi
potenti
pathway
toward
exonaa
revers
examin
possibl
singlenucleotid
substitut
surround
figur
three
mutat
synonym
five
mutat
yield
amino
acid
unlik
coordin
positivelycharg
metal
requir
exon
catalysi
glycin
valin
prolin
threonin
serin
one
mutat
per
site
restor
acid
charg
ie
aato
nativ
amino
acid
variant
test
cov
exon
biochem
studi
e
coli
dna
polymeras
exon
mutant
suggest
conserv
substitut
would
restor
wtlike
exon
activ
predict
stepwis
pathway
revers
base
restor
acid
charg
follow
revers
nativ
amino
acid
figur
engin
recov
variant
aa
requir
three
mutat
exonad
exonea
two
mutat
exonda
ed
exona
one
mutat
exondd
exone
revers
wtexond
tabl
hereaft
refer
mutant
intermedi
revert
intermedi
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
revert
gener
viabl
progeni
recoveri
demonstr
revers
de
along
pathway
theoret
possibl
mutant
genet
stabl
recoveri
confirm
dideoxi
sequenc
howev
mutant
dd
exone
revert
wtexond
three
independ
recoveri
attempt
suggest
two
variant
less
fit
wtexond
demonstr
revers
mutat
readili
access
test
whether
mutant
would
revert
rapidli
exonaa
passag
three
lineag
mutant
time
tabl
contrast
exona
contain
wtrevert
lineag
moi
pfucel
one
lineag
moi
pfucel
observ
wtrevert
domin
exona
popul
remain
passag
data
indic
least
one
mutat
pathway
lead
full
revers
tissu
cultur
probabl
exona
aris
singl
infecti
cycl
exonaa
low
theoret
achiev
exonaa
could
conceiv
revert
within
two
infecti
cycl
howev
complet
revers
never
observ
even
prolong
passag
persist
infect
suggest
addit
barrier
replic
fit
mainten
intermedi
revert
exist
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
gat
gaa
gca
gct
exon
motif
c
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
intermedi
revert
viabl
recombin
found
exonaa
popul
hypothes
confer
select
advantag
exonaa
test
hypothesi
first
analyz
replic
intermedi
revert
copyright
holder
preprint
peerreview
authorfund
copyright
holder
preprint
peerreview
authorfund
copyright
holder
preprint
peerreview
authorfund
significantli
sensit
figur
final
mutat
significantli
decreas
fit
rel
wtexond
figur
detect
statist
differ
specif
infect
wtexond
variant
isol
infect
figur
thu
mutat
aros
exonaa
background
detriment
replic
mutagen
sensit
competit
fit
presenc
fullyrevert
exond
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
result
also
extend
exist
studi
cov
exon
motif
motif
mutat
sarscov
dramat
reduc
nucleas
activ
biochem
assay
studi
examin
contribut
residu
independ
intermedi
revert
exonaa
display
consist
statist
differ
replic
sensit
competit
fit
rel
exonaa
suggest
remain
phenotyp
exon
infect
support
previou
studi
motif
de
essenti
wt
exon
function
given
result
surpris
observ
repeat
revers
exona
two
variant
exonda
exon
one
potenti
explan
specif
mutat
bia
exona
make
revert
mutat
access
exonda
exon
altern
exona
profound
replic
fit
defect
select
could
drive
primari
revers
quickli
away
genotyp
consist
hypothesi
exona
revert
quickli
higher
moi
natur
select
act
effici
larger
popul
size
tabl
consist
hypothesi
fit
effect
mutat
differ
base
motif
genotyp
benefici
exonaa
detriment
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
exond
background
previou
studi
difficult
determin
whether
fit
defect
exon
cov
directli
link
lowfidel
replic
mechan
data
suggest
proofread
function
uncoupl
gener
role
replic
figur
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
clone
recoveri
recombin
virus
sitedirect
mutagenesi
mhv
genom
fragment
perform
use
round
horn
pcr
origin
describ
briefli
adjac
primer
contain
mutat
interest
use
polynucleotid
kinas
neb
use
buffer
dna
ligas
contain
atp
pcr
perform
plasmid
templat
use
highfidel
previous
briefli
genom
rna
detect
fam
black
hole
quencher
label
probe
target
biosearch
technolog
petaluma
ca
rna
copi
number
calcul
refer
rna
standard
deriv
mhv
fragment
sampl
plate
technic
duplic
minim
welltowel
variat
titer
determin
plaqu
assay
cell
specif
infect
calcul
pfu
per
supernat
genom
rna
copi
sensit
assay
stock
solut
sigma
prepar
dimethyl
sulfoxid
dmso
sensit
assay
perform
plate
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
moi
pfucel
previous
describ
averag
valu
exclud
subsequ
analysi
duplic
well
differ
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
ct
rel
abund
competitor
refer
determin
subtract
ct
threshold
dctcompetitor
ctcompetitor
ctrefer
convert
reflect
foldchang
ratio
dratio
dct
competitor
plot
passag
number
chang
ie
slope
linear
regress
rel
fit
note
regress
fit
slight
deviat
ratio
input
skew
slope
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
